Kezdőlap › Mellrák › Minnesota › Minneapolis
Mellrák klinikai vizsgálatok: Minneapolis, MN
27 Mellrák vizsgálat keres résztvevőket Minneapolis és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
The Vanguard Study: Testing a New Way to Screen for Cancer
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- Minneapolis VA Medical Center, Minneapolis
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Toborzás folyamatban3. fázis
- Minnesota Oncology Hematology, P.A., Minneapolis
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Toborzás folyamatban3. fázis
- Minnesota Oncology Hematology P A, Minneapolis
- Allina Hlth Cancer Inst Minneapolis, Minneapolis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mérföldre
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Toborzás folyamatban2. fázis
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mérföldre
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Toborzás folyamatban2. fázis
- University of Minnesota, Masonic Cancer Center, Minneapolis
PRE-ISPY Phase I/II Oncology Platform Program
Toborzás folyamatban1/2. fázis
- University of Minnesota Masonic Cancer Center, Minneapolis
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Toborzás folyamatban2. fázis
- HealthPartners Frauenshuh Cancer Center, Saint Louis Park · 5 mérföldre
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Toborzás folyamatban3. fázis
- Clinical Trial Site, Minneapolis
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Toborzás folyamatban3. fázis
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- Metro-Minnesota Community Clinical Oncology, Saint Louis Park · 5 mérföldre
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Toborzás folyamatban3. fázis
- Healthpartners Regions Specialty Clinics, Saint Louis Park · 5 mérföldre
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Toborzás folyamatban3. fázis
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- Metro-MN Comm. Onc. Res Consortium, Saint Louis Park · 5 mérföldre
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Toborzás folyamatban3. fázis
- University of Minnesota Medical Center, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- University of Minnesota Masonic Cancer Center, Minneapolis
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Toborzás folyamatban3. fázis
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mérföldre
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Toborzás folyamatban2/3. fázis
- Local Institution - 0372, Minneapolis
Fast-Her: Fasting Effects on Breast Cancer Treatment
Toborzás folyamatban
- University of Minnesota, Minneapolis
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Toborzás folyamatban3. fázis
- Allina Health System DBA Virginia Piper Cancer Institute, Minneapolis
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Toborzás folyamatban2. fázis
- University of Minnesota, Minneapolis
- Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park · 5 mérföldre
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Toborzás folyamatban3. fázis
- Minnesota Oncology Hematology, P.A., Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
Toborzás folyamatban2. fázis
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 mérföldre
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Toborzás folyamatban3. fázis
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mérföldre
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Toborzás folyamatbanMegfigyeléses tanulmány
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mérföldre
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Allina Health Cancer Institute, Minneapolis
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Toborzás folyamatbanMegfigyeléses tanulmány
- Metro Minnesota Community Oncology Consortium (MMCORC), Saint Louis Park · 5 mérföldre
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Toborzás folyamatban3. fázis
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mérföldre
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Toborzás folyamatbanMegfigyeléses tanulmány
- Minnesota Oncology, Minneapolis
Mellrák vizsgálatok más városokban
- New York City, NY136 tanulmány
- Houston, TX126 tanulmány
- Boston, MA112 tanulmány
- Nashville, TN81 tanulmány
- Los Angeles, CA73 tanulmány
- Edison, NJ68 tanulmány
- St. Louis, MO64 tanulmány
- Queens, NY64 tanulmány
- Durham, NC64 tanulmány
- Chicago, IL59 tanulmány
- Philadelphia, PA56 tanulmány
- Dallas, TX55 tanulmány
Egyéb vizsgálatok: Minneapolis
- Nem kis sejtes tüdőrák27 tanulmány
- Petefészekrák24 tanulmány
- Prosztatarák23 tanulmány
- Rák (minden típus)22 tanulmány
- Szívelégtelenség21 tanulmány
- Akut mieloid leukémia20 tanulmány
- Tüdőrák20 tanulmány
- Kolorektális rák19 tanulmány
- Endometriális rák18 tanulmány
- Parkinson-kór17 tanulmány
- Szív- és érrendszeri betegségek15 tanulmány
- Koszorúér-betegség13 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.